|
|
Comparison of the Short-term Efficacy and Stress Reactions in Patients with Gastric Cancer Treated by Laparoscopic Surgery and Open Surgery |
WANG Jing-dong, ZHANG Tao, Adili,et al |
Department of General Surgery,Xinjiang PAP Corps Hospital,Urumqi ,Xingjiang, 830001 ,China |
|
|
Abstract 【Objective】 To compare the short-term efficacy and stress reactions in patients with gastric cancer treated by laparoscopic surgery and open surgery. 【Methods】The data of 128 patients with gastric cancer treated by D2 radical resection were retrospectively analyzed. They were divided into the laparoscopic group (A,n=68) and the open group (B,n=60) according to different surgical methods. The postoperative complications, short-term efficacy and stress reactions before surgery, 1 and 5days after surgery were compared between groups. 【Results】The number of dissected lymph nodes was (21.36±7.69), distance from the near end to tumor margin was (4.86±0.94) cm and the distance from the distal end to tumor margin was (4.32±0.76) cm, while those of the group B were (22.36±9.26)、(5.08±1.02)cm and (4.51±0.84)cm, respectively, the two groups showed no significant differences (P>0.05). One day after surgery, serum IL-6 and CRP levels increased significantly(P<0.05), and then decreased at d5 post operation(P<0.05), while IL-10 decreased at d1 after surgery(P<0.05)and then increased at d5 (P<0.05), and the changes of the group A were significantly lower than those of the group B (P<0.05).【Conclusion】 The effects of both laparoscopic surgery and open surgery are good in the treatment of gastric cancer but the former is more minimally invasive and patients can recover fast, and it has little effect on the stress reactions in patients as well.
|
Received: 07 December 2016
|
|
|
|
|
[1] 胡军,周琴,吴克雄,等.表柔比星联合奥沙利铂与卡培他滨方案治疗晚期胃癌的临床观察[J].现代肿瘤医学,2013,21(11):2536-2538. [2] 陈守华,王建红,田思源,等.OLF方案和EOF方案一线治疗晚期胃癌的疗效观察[J].当代医学,2013,7(35):77-78. [3] 秦晓冰,李金运,于韬,等.ECF与DOF方案治疗晚期胃癌的临床疗效观察[J].重庆医学,2015,37(11):1512-1513,1521. [4] 王育生,李秀秀,温璐,等.改良表柔比星+奥沙利铂+氟尿嘧啶方案联合树突状细胞-细胞因子诱导的杀伤细胞治疗晚期胃癌临床疗效观察[J].中国药物与临床,2015,18(1):18-21. [5] 李建旺,黄春珍,陈琼慧,等.mEOX与FOLFIRI方案二线治疗晚期胃癌疗效对照观察[J].中华肿瘤防治杂志,2016,23(14):952-957. [6] 李建旺,黄春珍,元建华,等.伊立替康联合顺铂对比伊立替康单药二线治疗晚期胃癌的临床研究[J].临床肿瘤学杂志,2016,21(6):540-544. [7] 崔勇霞,罗执芬,卢创新,等.伊立替康联合替吉奥或5-氟尿嘧啶方案二线治疗晚期胃癌的疗效观察[J].肿瘤防治研究,2014,41(7):808-810. [8] 王清波,冯继锋,陆建伟,等.伊立替康联合雷替曲塞二线治疗晚期胃癌的疗效分析[J].临床肿瘤学杂志,2015,13(10):909-912. (本文编辑:王沪湘) [收稿日期] 2016-12-07
|
|
|
|